Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy

Ilett, E, Kottke, T, Thompson, J et al. (12 more authors) (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy. Gene Therapy, 24 (1). pp. 21-30. ISSN 0969-7128

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Macmillan Publishers Limited. All rights reserved. This is an author produced version of a paper published in Gene Therapy. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: January 2017
  • Accepted: 4 October 2016
  • Published (online): 25 October 2016
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 28 Oct 2016 10:16
Last Modified: 18 Jul 2017 05:50
Published Version: https://doi.org/10.1038/gt.2016.70
Status: Published
Publisher: Nature Publishing Group
Identification Number: https://doi.org/10.1038/gt.2016.70

Share / Export

Statistics